167 related articles for article (PubMed ID: 19379743)
1. BS69 negatively regulates the canonical NF-kappaB activation induced by Epstein-Barr virus-derived LMP1.
Ikeda O; Sekine Y; Mizushima A; Oritani K; Yasui T; Fujimuro M; Muromoto R; Nanbo A; Matsuda T
FEBS Lett; 2009 May; 583(10):1567-74. PubMed ID: 19379743
[TBL] [Abstract][Full Text] [Related]
2. BS69 cooperates with TRAF3 in the regulation of Epstein-Barr virus-derived LMP1/CTAR1-induced NF-kappaB activation.
Ikeda O; Miyasaka Y; Yoshida R; Mizushima A; Oritani K; Sekine Y; Kuroda M; Yasui T; Fujimuro M; Muromoto R; Nanbo A; Matsuda T
FEBS Lett; 2010 Mar; 584(5):865-72. PubMed ID: 20138174
[TBL] [Abstract][Full Text] [Related]
3. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1).
Eliopoulos AG; Young LS
Oncogene; 1998 Apr; 16(13):1731-42. PubMed ID: 9582021
[TBL] [Abstract][Full Text] [Related]
4. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.
Adriaenssens E; Mougel A; Goormachtigh G; Loing E; Fafeur V; Auriault C; Coll J
Oncogene; 2004 Apr; 23(15):2681-93. PubMed ID: 14767477
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus latent membrane protein-1 (LMP1) C-terminus activation region 2 (CTAR2) maps to the far C-terminus and requires oligomerisation for NF-kappaB activation.
Floettmann JE; Rowe M
Oncogene; 1997 Oct; 15(15):1851-8. PubMed ID: 9362452
[TBL] [Abstract][Full Text] [Related]
6. BS69, a specific adaptor in the latent membrane protein 1-mediated c-Jun N-terminal kinase pathway.
Wan J; Zhang W; Wu L; Bai T; Zhang M; Lo KW; Chui YL; Cui Y; Tao Q; Yamamoto M; Akira S; Wu Z
Mol Cell Biol; 2006 Jan; 26(2):448-56. PubMed ID: 16382137
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-encoded LMP1 promotes cisplatin-induced caspase activation through JNK and NF-kappaB signaling pathways.
Zhang X; Sanmun D; Hu L; Fadeel B; Ernberg I
Biochem Biophys Res Commun; 2007 Aug; 360(1):263-8. PubMed ID: 17586463
[TBL] [Abstract][Full Text] [Related]
8. Pursuing different 'TRADDes': TRADD signaling induced by TNF-receptor 1 and the Epstein-Barr virus oncoprotein LMP1.
Kieser A
Biol Chem; 2008 Oct; 389(10):1261-71. PubMed ID: 18713013
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus latent membrane protein-1 (LMP1) signalling is distinct from CD40 and involves physical cooperation of its two C-terminus functional regions.
Floettmann JE; Eliopoulos AG; Jones M; Young LS; Rowe M
Oncogene; 1998 Nov; 17(18):2383-92. PubMed ID: 9811470
[TBL] [Abstract][Full Text] [Related]
10. The latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus induces expression of the putative oncogene Bcl-3 through activation of the nuclear factor-kappaB.
Nakamura H; Ishii C; Suehiro M; Iguchi A; Kuroda K; Shimizu K; Shimizu N; Imadome K; Yajima M; Fujiwara S
Virus Res; 2008 Feb; 131(2):170-9. PubMed ID: 17963943
[TBL] [Abstract][Full Text] [Related]
11. The A20 protein interacts with the Epstein-Barr virus latent membrane protein 1 (LMP1) and alters the LMP1/TRAF1/TRADD complex.
Fries KL; Miller WE; Raab-Traub N
Virology; 1999 Nov; 264(1):159-66. PubMed ID: 10544141
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2.
Eliopoulos AG; Blake SM; Floettmann JE; Rowe M; Young LS
J Virol; 1999 Feb; 73(2):1023-35. PubMed ID: 9882303
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr Virus and its glycoprotein-350 upregulate IL-6 in human B-lymphocytes via CD21, involving activation of NF-kappaB and different signaling pathways.
D'Addario M; Libermann TA; Xu J; Ahmad A; Menezes J
J Mol Biol; 2001 May; 308(3):501-14. PubMed ID: 11327783
[TBL] [Abstract][Full Text] [Related]
14. Zfra affects TNF-mediated cell death by interacting with death domain protein TRADD and negatively regulates the activation of NF-kappaB, JNK1, p53 and WOX1 during stress response.
Hong Q; Hsu LJ; Schultz L; Pratt N; Mattison J; Chang NS
BMC Mol Biol; 2007 Jun; 8():50. PubMed ID: 17567906
[TBL] [Abstract][Full Text] [Related]
15. Oligomerized TICAM-1 (TRIF) in the cytoplasm recruits nuclear BS69 to enhance NF-kappaB activation and type I IFN induction.
Takaki H; Oshiumi H; Sasai M; Kawanishi T; Matsumoto M; Seya T
Eur J Immunol; 2009 Dec; 39(12):3469-76. PubMed ID: 19795416
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus latent membrane protein 1 represses p53-mediated DNA repair and transcriptional activity.
Liu MT; Chang YT; Chen SC; Chuang YC; Chen YR; Lin CS; Chen JY
Oncogene; 2005 Apr; 24(16):2635-46. PubMed ID: 15829976
[TBL] [Abstract][Full Text] [Related]
17. A role for protein kinase PKR in the mediation of Epstein-Barr virus latent membrane protein-1-induced IL-6 and IL-10 expression.
Lin SS; Lee DC; Law AH; Fang JW; Chua DT; Lau AS
Cytokine; 2010 May; 50(2):210-9. PubMed ID: 20171114
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K.
Mainou BA; Everly DN; Raab-Traub N
Oncogene; 2005 Oct; 24(46):6917-24. PubMed ID: 16007144
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus latent membrane protein 1 modulates epidermal growth factor receptor promoter activity in a nuclear factor kappa B-dependent manner.
Tao YG; Tan YN; Liu YP; Song X; Zeng L; Gu HH; Tang M; Li W; Yi W; Cao Y
Cell Signal; 2004 Jul; 16(7):781-90. PubMed ID: 15115657
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus encoded latent membrane protein 1 induces TRAF1 expression to promote anti-apoptosis activity via NF-kappaB signaling pathway in nasopharyngeal carcinoma.
Wang C; Ai M; Ren W; Xiao H; Li X; Tang F; Gu H; Yi W; Weng X; Deng X; Cao Y
Chin Med J (Engl); 2003 Jul; 116(7):1022-8. PubMed ID: 12890376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
